Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory, with Excess of Blasts

Explore clinical trials studying Anemia, Refractory, with Excess of Blasts. Study availability and eligibility vary by location and protocol.

249 public trials 37 recruiting studies

Anemia, Refractory, with Excess of Blasts trial results

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations
  • BMT Program at Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Westwood, Kansas, United States
  • Roswell Park Buffalo, New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +11 more
Locations
  • The Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospital Bristol Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
View all 20 locations
Conditions
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monocytic Leukemia, +31 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Kaiser Permanente-San Diego Mission San Diego, California, United States
View all 341 locations
Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States